Stock comparison
Mettler-Toledo International
Organon &
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
OGN
Organon &
Market cap
$3.53B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MTD | OGN | Winner |
|---|---|---|---|
| Warren Buffett | 69B | 57C | MTD |
| Benjamin Graham | 65B | 78B | OGN |
| Philip Fisher | 63C | 38D | MTD |
| Peter Lynch | 66B | 27F | MTD |
| Joel Greenblatt | 68B | 21F | MTD |
| Charlie Munger | 74B | 48D | MTD |
| Terry Smith | 70B | 46D | MTD |
Side-by-side metrics
| Metric | MTD | OGN |
|---|---|---|
| Market cap | $22.29B | $3.53B |
| P/E (TTM) | 25.3x | 14.2x |
| EV/EBIT | 21.6x | 8.5x |
| ROIC (TTM) | 36.09% | 5.16% |
| Gross margin | 57.79% | 53.11% |
| Net margin | 21.4% | 3.99% |
| Revenue CAGR 5y | 2.01% | -0.35% |
| EPS CAGR 5y | 6.12% | -39.38% |
| Debt / Equity | - | 9.5x |
| Dividend yield | 0.0% | 0.6% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MTD leads on
- Debt / Equity-vs 9.5x+118%
- Revenue CAGR 5y2.01%vs -0.35%+117%
- EPS CAGR 5y6.12%vs -39.38%+116%
- ROIC (TTM)36.09%vs 5.16%+86%
OGN leads on
- Dividend yield0.6%vs 0.0%+100%
- EV/EBIT8.5xvs 21.6x+61%
- P/E (TTM)14.2xvs 25.3x+44%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.